Joel T. Arcari

631 total citations
10 papers, 124 citations indexed

About

Joel T. Arcari is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Joel T. Arcari has authored 10 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Joel T. Arcari's work include Asymmetric Synthesis and Catalysis (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Synthesis of β-Lactam Compounds (2 papers). Joel T. Arcari is often cited by papers focused on Asymmetric Synthesis and Catalysis (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Synthesis of β-Lactam Compounds (2 papers). Joel T. Arcari collaborates with scholars based in United States and United Kingdom. Joel T. Arcari's co-authors include Amy R. Howell, Arnold L. Rheingold, Gan Wang, Albert Ndakala, Ying Wang, Mehrnoosh Hashemzadeh, Mark J. Mitton‐Fry, Robert M. Oliver, Ying Wang and Justin I. Montgomery and has published in prestigious journals such as The Journal of Organic Chemistry, Organic Letters and Tetrahedron Letters.

In The Last Decade

Joel T. Arcari

10 papers receiving 118 citations

Peers

Countries citing papers authored by Joel T. Arcari

Since Specialization

Citations

This map shows the geographic impact of Joel T. Arcari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel T. Arcari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel T. Arcari more than expected).

Fields of papers citing papers by Joel T. Arcari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel T. Arcari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel T. Arcari. The network helps show where Joel T. Arcari may publish in the future.

Co-authorship network of co-authors of Joel T. Arcari

This figure shows the co-authorship network connecting the top 25 collaborators of Joel T. Arcari. A scholar is included among the top collaborators of Joel T. Arcari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel T. Arcari. Joel T. Arcari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Rapid Multikilogram Scale-Up of Di- and Trifluoromethoxy Proline Derivatives 2024 ·Organic Process Research & Development ·Pablo J. Cabrera, Christophe Allais, Joel T. Arcari, María González‐Esguevillas, Emma L. McInturff, Matthew R. Reese	1
2	Demonstration of a Multikilogram-Scale Birch Reduction and Evaluation of Alternative Synthetic Routes to a Ketalized Cyclohexene Derivative 2023 ·Organic Process Research & Development ·Adam E. Goetz, Joel T. Arcari, Scott W. Bagley, Robert W. Hicklin, (unknown), (unknown), Xinnan Li, Zhiqing Liu, J. Christopher McWilliams, Mihir D. Parikh, Tyler J. Potter, William Smith, Lijie Sun, John I. Trujillo, Pan Wang, Xin Zhao	7
3	Process Development for the Synthesis of Monocyclic β-Lactam Core 17 2018 ·Organic Process Research & Development ·Manjinder S. Lall, Yong Tao, Joel T. Arcari, (unknown), Matthew F. Brown, David B. Damon, (unknown), Mark J. Mitton‐Fry, Jeremy T. Starr, (unknown), Jianmin Sun	12
4	Optimization of amide-based EP3 receptor antagonists 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Kentaro Futatsugi, Joel T. Arcari, Kevin B. Bahnck, Steven B. Coffey, David R. Derksen, Amit S. Kalgutkar, Paula M. Loria, Raman Sharma	5
5	Discovery and characterization of a novel class of pyrazolopyrimidinedione tRNA synthesis inhibitors 2014 ·The Journal of Antibiotics ·Justin I. Montgomery, James F. Smith, Andrew P. Tomaras, Richard P. Zaniewski, Craig J. McPherson, Laura A. McAllister, (unknown), Joel T. Arcari, (unknown), Jemy A. Gutierrez, (unknown), Chris Limberakis, Alita A. Miller	12
6	Total synthesis of (±)-monomorine 2012 ·Tetrahedron Letters ·(unknown), Robert M. Oliver, Joel T. Arcari, Mark J. Mitton‐Fry	10
7	One-Pot (1-Ethoxycarbonylcyclopropyl)triphenylphosphonium Tetrafluoroborate Ring-Opening and Wittig Reaction 2011 ·Organic Letters ·Seung Won Chung, Mark S. Plummer, Laura A. McAllister, Robert M. Oliver, J. A. Abramite, Yue Shen, Jianmin Sun, Daniel P. Uccello, Joel T. Arcari, Loren Price, Justin I. Montgomery	3
8	The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer 2007 ·Bioorganic & Medicinal Chemistry Letters ·Blaise Lippa, Goss S. Kauffman, Joel T. Arcari, (unknown), Jinshan Chen, (unknown), Samit K. Bhattacharya, (unknown), (unknown), Jun Xiao, Leslie R. Pustilnik, Chunyan Su, James D. Moyer, Ling Ma, Mary E. Campbell, Stefanus J. Steyn	20
9	Preparation and Properties of 2-Methyleneoxetanes 1999 ·The Journal of Organic Chemistry ·(unknown), Albert Ndakala, Mehrnoosh Hashemzadeh, Gan Wang, Ying Wang, (unknown), Joel T. Arcari, (unknown), Amy R. Howell, Arnold L. Rheingold, (unknown)	44
10	1-Iodomethyl-3,4-diphenyl-2,6-dioxabicyclo[2.2.0]hexane: the first example of a [2.2.0] fused ketal 1999 ·Tetrahedron Letters ·Gan Wang, Ying Wang, Joel T. Arcari, Amy R. Howell, Arnold L. Rheingold, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact